Cost of Care with Everolimus Versus Axitinib for Second-Line Metastatic Renal Cell Carcinoma Patients in Canada
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.458
https://www.valueinhealthjournal.com/article/S1098-3015(13)02363-2/fulltext
Title :
Cost of Care with Everolimus Versus Axitinib for Second-Line Metastatic Renal Cell Carcinoma Patients in Canada
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)02363-2&doi=10.1016/j.jval.2013.08.458
First page :
A402
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
440